Balanced news tone
News Sentiment
ORNBV sentiment intelligence
Orion Oyj news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
79/100 classification confidence.
directly relevant articles
high-authority source matches
+11.1% over one week, +15.9% over four weeks, trend active, and materially above fair value.
Orion stock holds as investors await the next catalyst
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Orion stock holds as investors await the next catalyst
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jul 2026 04:45
- Source
- ad-hoc-news.de
Orion Q2 2026 slides: Nubeqa drives 69% profit surge, stock hits high
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 17 Jul 2026 12:17
- Source
- Investing.com
Orion Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jul 2026 12:07
- Source
- marketscreener.com
Why is Orion Oyj B stock surging today?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 10:12
- Source
- Investing.com
Orion stock jumps 8% as Q2 net sales climb 25% By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 10:08
- Source
- Investing.com Nigeria
Orion Oyj (ORNBV) Earnings: Forecast Revision and Strong Q2 Results Drive Stock Upward
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 17 Jul 2026 09:11
- Source
- Smartkarma
45,611 Orion Corporation A shares converted into B shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 06:00
- Source
- marketscreener.com
Orion focuses on pharmaceuticals and animal health as investors watch global peers.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 07:05
- Source
- ad-hoc-news.de
Orion Oyj focuses on pharmaceuticals and global growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 Jul 2026 10:39
- Source
- ad-hoc-news.de
Is Orion Oyj (HLSE:ORNBV) A Bargain On Its New Nivolumab Biosimilar Deal?
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 08 Jul 2026 01:53
- Source
- simplywall.st
Orion stock extends its Helsinki listing focus. Investors watch the Finnish drugmaker's steady busin
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jul 2026 09:50
- Source
- ad-hoc-news.de
Orion Oyj focuses on pharmaceuticals and diagnostics as investors watch long-term growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Jul 2026 07:57
- Source
- ad-hoc-news.de
Orion Oyj focuses on pharmaceuticals and innovation as investors weigh long-term growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Jul 2026 10:58
- Source
- ad-hoc-news.de
Orion Oyj focuses on pharmaceuticals and generics as investors watch global healthcare demand
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 01 Jul 2026 14:13
- Source
- ad-hoc-news.de
Orion prepares for substantial growth amid broader market moves
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- ad-hoc-news.de
Orion Oyj sees BlackRock stake cross 5 percent, shares in focus for Helsinki investors
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 26 Jun 2026 07:00
- Source
- ad-hoc-news.de
Orion Stock - Thursday chart update and technical picture
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- ad-hoc-news.de
FDA Approval Of Tessie Puts Orion’s Animal Health Potential In Focus
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 19 May 2026 07:00
- Source
- simplywall.st
Inside information: Orion provides outlook for 2026 and
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 14 Jan 2026 08:00
- Source
- GlobeNewswire
Orion Oyj: Target Price Consensus and Analysts Recommendations | ORNBV | FI0009014377
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 18 Aug 2020 18:55
- Source
- marketscreener.com